Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics.
BACKGROUND
Staphylococcus aureus activates a protective cell wall stress stimulon (CWSS) in response to the inhibition of cell wall synthesis or cell envelope damage caused by several structurally and functionally different antibiotics. CWSS induction is coordinated by the VraSR two-component system, which senses an unknown signal triggered by diverse cell wall active agents.


RESULTS
We have constructed a highly sensitive luciferase reporter gene system, using the promoter of sas016 (S. aureus N315), which detects very subtle differences in expression as well as measuring > 4 log-fold changes in CWSS activity, to compare the concentration dependence of CWSS induction kinetics of antibiotics with different cell envelope targets. We compared the effects of subinhibitory up to suprainhibitory concentrations of fosfomycin, D-cycloserine, tunicamycin, bacitracin, flavomycin, vancomycin, teicoplanin, oxacillin, lysostaphin and daptomycin. Induction kinetics were both strongly antibiotic- and concentration-dependent. Most antibiotics triggered an immediate response with induction beginning within 10 min, except for tunicamycin, D-cycloserine and fosfomycin which showed lags of up to one generation before induction commenced. Induction characteristics, such as the rate of CWSS induction once initiated and maximal induction reached, were strongly antibiotic dependent. We observed a clear correlation between the inhibitory effects of specific antibiotic concentrations on growth and corresponding increases in CWSS induction kinetics. Inactivation of VraR increased susceptibility to the antibiotics tested from 2- to 16-fold, with the exceptions of oxacillin and D-cycloserine, where no differences were detected in the methicillin susceptible S. aureus strain background analysed. There was no apparent correlation between the induction capacity of the various antibiotics and the relative importance of the CWSS for the corresponding resistance phenotypes.


CONCLUSIONS
CWSS induction profiles were unique for each antibiotic. Differences observed in optimal induction conditions for specific antibiotics should be determined and taken into account when designing and interpreting CWSS induction studies.
Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Vanina
V
Dengler
Patricia Stutzmann
PS
Meier
Ronald
R
Heusser
Brigitte
B
Berger-Bächi
Nadine
N
McCallum
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism*; D002473:Cell Wall / Q000378:metabolism*; D015964:Gene Expression Regulation, Bacterial; D017930:Genes, Reporter; D007700:Kinetics; D008826:Microbial Sensitivity Tests; D011401:Promoter Regions, Genetic; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; C478169:VraS protein, Staphylococcus aureus
Ann N Y Acad Sci. 1974 May 10;235(0):364-86
4605290
Antimicrob Agents Chemother. 2006 Oct;50(10):3424-34
17005825
J Bacteriol. 2009 May;191(9):2973-84
19251860
Antimicrob Agents Chemother. 1995 Mar;39(3):781-5
7793894
J Bacteriol. 2006 Jul;188(14):5153-66
16816187
Antimicrob Agents Chemother. 1996 Jul;40(7):1640-4
8807054
FEMS Microbiol Lett. 2006 Sep;262(2):163-71
16923071
Appl Microbiol Biotechnol. 2008 Sep;80(4):555-61
18607587
Annu Rev Microbiol. 1991;45:37-67
1741619
J Bacteriol. 2007 Mar;189(6):2376-91
17194794
Antimicrob Agents Chemother. 2004 Jun;48(6):1953-9
15155184
Biochemistry. 1979 May 29;18(11):2186-92
444447
ACS Chem Biol. 2009 Oct 16;4(10):875-83
19689117
Antimicrob Agents Chemother. 2007 Nov;51(11):3836-43
17709474
Antimicrob Agents Chemother. 2009 Mar;53(3):1231-4
19124662
Nature. 1983 Oct 20-26;305(5936):709-12
6226876
Mol Microbiol. 2003 Aug;49(3):807-21
12864861
Microbiology (Reading). 2010 May;156(Pt 5):1372-1383
20167623
Microbiology (Reading). 2003 Oct;149(Pt 10):2719-2732
14523105
Proc Natl Acad Sci U S A. 1971 Dec;68(12):3223-7
4332017
Antimicrob Agents Chemother. 2003 Aug;47(8):2558-64
12878519
Antimicrob Agents Chemother. 2004 Aug;48(8):3057-63
15273121
FEMS Microbiol Rev. 2008 Jan;32(1):107-46
18173394
J Bacteriol. 2006 Feb;188(3):1120-33
16428416
Biochem Pharmacol. 2006 Mar 30;71(7):957-67
16298347
J Bacteriol. 1977 Jun;130(3):1055-63
405370
Antimicrob Agents Chemother. 2008 Mar;52(3):980-90
18086846
Mol Microbiol. 2009 Apr;72(2):335-43
19298367
BMC Genomics. 2009 Sep 14;10:429
19751498
Anal Biochem. 1994 Nov 1;222(2):511-4
7532381
J Biol Chem. 2008 May 2;283(18):12354-64
18326495
J Membr Biol. 2008 Sep-Oct;225(1-3):27-37
18855038
J Bacteriol. 1989 Apr;171(4):2252-7
2703473
Antimicrob Agents Chemother. 2004 Aug;48(8):2888-96
15273097
Nucleic Acids Res. 1995 Aug 25;23(16):3357-8
7545288
J Bacteriol. 1972 Jun;110(3):978-87
4555420
J Biol Chem. 2007 Nov 30;282(48):35143-52
17925392
J Bacteriol. 1983 Apr;154(1):479-87
6300037
Biochim Biophys Acta. 2006 Oct;1760(10):1475-81
16891058
Int J Med Microbiol. 2010 Feb;300(2-3):118-29
19800843
Antimicrob Agents Chemother. 2008 Aug;52(8):2923-5
18541730
J Antimicrob Chemother. 2010 Jan;65(1):37-45
19889788
Antimicrob Agents Chemother. 2011 Apr;55(4):1391-402
21220524
Mol Microbiol. 2010 May;76(4):905-17
20384696
Biochemistry. 2009 Jun 23;48(24):5592-601
19419158
Plasmid. 2006 Jan;55(1):58-63
16051359
Curr Opin Chem Biol. 2009 Apr;13(2):144-51
19303806